Reinhard Vogt

Reinhard Vogt was a Venture Partner at Dynamk Capital and Chairman of Scientific Bioprocessing Inc., focusing on life science tools startups. Prior to his transition to venture capital, he spent over 35 years at Sartorius AG, where he served as Executive Vice President and a board member for both Sartorius AG and Sartorius Stedim Biotech S.A. During his tenure, he drove significant global expansion, helping grow the company's revenue from $90 million to nearly $3 billion and increasing its market capitalization from under $100 million to $24 billion. He also led more than 12 strategic acquisitions, including TAP Biosystems and Cellca, and held board positions at AVANT BIO and Sarstedt AG, where he began his career. Prior to his passing, Vogt leveraged his extensive bioprocessing expertise to mentor founders and finance early-stage biotechnology commercialization efforts.